Risk of HCC: genetic heterogeneity and complex genetics.
暂无分享,去创建一个
[1] A. Tamakoshi,et al. Risk of death due to hepatocellular carcinoma among drinkers and ex-drinkers. Univariate analysis of JACC study data. , 2004, The Kurume medical journal.
[2] Y. Liaw,et al. Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study , 2009, European Journal of Human Genetics.
[3] Lu-Yu Hwang,et al. Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.
[4] A. Pietrangelo. Hereditary hemochromatosis--a new look at an old disease. , 2004, The New England journal of medicine.
[5] C. Badenas,et al. Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives , 2009, Clinical genetics.
[6] N. Chalasani,et al. Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis? , 2003, Journal of clinical gastroenterology.
[7] P. Su,et al. Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a Chinese population. , 2008, Asian Pacific journal of cancer prevention : APJCP.
[8] M. Badminton,et al. Liver transplantation for porphyria: Who, when, and how? , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] M. Ziol,et al. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis , 2009, Hepatology.
[10] R. Hultcrantz,et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.
[11] A. Tavill,et al. Liver Disease in Alpha 1-Antitrypsin Deficiency: A Review , 2008, The American Journal of Gastroenterology.
[12] E. Mayatepek,et al. Molecular genetics of type 1 glycogen storage disease. , 2001, Molecular genetics and metabolism.
[13] J. Faivre,et al. Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. , 2000, Journal of hepatology.
[14] H. Adami,et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma , 2000, International journal of cancer.
[15] I. König,et al. Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol‐associated cancer in heavy drinkers , 2006, International journal of cancer.
[16] Manal M. Hassan,et al. Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States , 2009, Hepatology.
[17] Philip J. Lee,et al. Glycogen storage disease type I: pathophysiology of liver adenomas , 2002, European Journal of Pediatrics.
[18] C. Wild,et al. The toxicology of aflatoxins as a basis for public health decisions. , 2002, Mutagenesis.
[19] M. Taniai,et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2009, Journal of Gastroenterology.
[20] S. Sandberg,et al. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. , 2009, Clinical chemistry.
[21] H. El‐Serag,et al. Risk factors for the rising rates of primary liver cancer in the United States. , 2000, Archives of internal medicine.
[22] L. Bianchi. Glycogen storage disease I and hepatocellular tumours , 2005, European Journal of Pediatrics.
[23] A. Burroughs,et al. Hepatocellular carcinoma , 2003, The Lancet.
[24] W. London,et al. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[25] F. Alvarez,et al. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. , 2009, World journal of gastroenterology.
[26] K. Hemminki,et al. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden , 2003, Gut.
[27] E. Taioli,et al. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. , 2001, Journal of hepatology.
[28] Robert P. Clickner,et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). , 2007, Thyroid : official journal of the American Thyroid Association.
[29] Tara L. Kieffer,et al. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .
[30] J. Florez. The Genetics of Type 2 Diabetes: A Realistic Appraisal in 2008 , 2008 .
[31] H. El‐Serag,et al. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[32] A. Green,et al. Cancer and diabetes ‐ a follow‐up study of two populationbased cohorts of diabetic patients , 1997, Journal of internal medicine.
[33] R. E. de Salamanca,et al. ASSOCIATION OF PORPHYRIA CUTANEA TARDA AND PRIMARY LIVER CANCER: REPORT OF TEN CASES , 1982, The Journal of dermatology.
[34] K. Kowdley,et al. HFE-associated hereditary hemochromatosis , 2009, Genetics in Medicine.
[35] C. Mize,et al. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. , 1976, The Journal of pediatrics.
[36] V. Saudek,et al. Acute intermittent porphyria – impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties , 2009, The FEBS journal.
[37] V. Carreño,et al. Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors. , 1985, Journal of hepatology.
[38] D. Calvisi,et al. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. , 2006, Biochimica et biophysica acta.
[39] K. Straif,et al. Carcinogenicity of alcoholic beverages. , 2007, The Lancet. Oncology.
[40] J. Gisbert,et al. Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. , 2003, Journal of hepatology.
[41] D. Frush,et al. Hepatocellular carcinoma in glycogen storage disease type Ia: A case series , 2005, Journal of Inherited Metabolic Disease.
[42] H. Adami,et al. Excess risk of primary liver cancer in patients with diabetes mellitus. , 1996, Journal of the National Cancer Institute.
[43] P. Schirmacher,et al. Autocrine insulin‐like growth factor‐II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis , 2008, Hepatology.
[44] T. Luedde,et al. Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .
[45] J. Haddow,et al. Original Paper: Hereditary haemochromatosis and hepatocellular carcinoma in males: a strategy for estimating the potential for primary prevention , 2003 .
[46] M. Gariboldi,et al. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. , 1994, Genomics.
[47] A. Bergquist,et al. Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients. , 2009, Journal of hepatology.
[48] M. King,et al. Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. , 1991, American journal of human genetics.
[49] Shankar Subramaniam,et al. Diet‐induced hepatocellular carcinoma in genetically‐predisposed mice , 2009, Human molecular genetics.
[50] B. Zawirska,et al. Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias. , 1983, Gastroenterology.
[51] Katsutoshi Tokushige,et al. Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C , 2009, Journal of gastroenterology and hepatology.
[52] H. El‐Serag,et al. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. , 2008, American journal of epidemiology.
[53] B. Bacon,et al. Hereditary hemochromatosis in the post‐HFE era , 2008, Hepatology.
[54] J. Leonard,et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I) , 2007, European Journal of Pediatrics.
[55] E. Negri,et al. Liver cirrhosis and the risk of primary liver cancer , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[56] Fuchu He,et al. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case–control study in a high-risk region of China , 2006, Pharmacogenetics and genomics.
[57] T. Luedde,et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.
[58] D. Calvisi,et al. Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats , 2004, International journal of cancer.
[59] C. K. Hsiao,et al. Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area , 2006, Oncogene.
[60] M. Gariboldi,et al. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. , 1993, Cancer research.
[61] H. Whittle,et al. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. , 2004, Pharmacogenetics.
[62] M. McCarthy,et al. Underlying genetic models of inheritance in established type 2 diabetes associations. , 2009, American journal of epidemiology.
[63] T. Dragani,et al. Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis. , 1986, Cancer letters.
[64] D. Calvisi,et al. Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10. , 1999, Cancer research.
[65] T. Dragani,et al. Genetic control of resistance to hepatocarcinogenesis by the mouse Hpcr3 locus , 2008, Hepatology.
[66] Josepa Ribes,et al. Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.
[67] S. Eriksson,et al. Risk of hepatobiliary disease in adults with severe α1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? , 1996, European journal of gastroenterology & hepatology.
[68] D. Harrison,et al. Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis , 2000, Molecular pathology : MP.
[69] D. García-Compeán,et al. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. , 2009, World journal of gastroenterology.
[70] C. Scott. The genetic tyrosinemias , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.
[71] C. la Vecchia,et al. Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy , 2006, Cancer Epidemiology Biomarkers & Prevention.
[72] M. Thun,et al. Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.